Our Science

See how our scientific innovation and expertise can support your inhaled development programme

Find out more

Product development

Tailored inhalation services for you

Track record

Choose a partner to help you succeed


Vectura provides update on GSK litigation


Vectura Group plc (LSE: VEC) (“Vectura”), an industry-leading inhalation CDMO, announces that the United States Court of Appeals for the...

Will Downie’s podcast: “There’s a patient at the end of every piece of work we do…”


In the latest podcast in our series,  Will Downie, Vectura’s CEO, talks about coping with the COVID crisis, our CDMO...